Built on Long-Term Innovation: Hangzhou Zhengda Medical's Continuous R&D Journey

In the medical device industry, long-term success depends on continuous innovation and technical expertise rather than short-term achievements. A company's growth relies on its ability to build strong R&D capabilities and maintain consistent technological advancement over time.

Since its founding, Hangzhou Zhengda Medical Co., Ltd. has placed innovation at the core of its strategy. By investing steadily in research and development, the company has built a substantial intellectual property portfolio and extensive experience across multiple medical device categories.

Today, Hangzhou Zhengda Medical holds 46 patents and 13 software copyrights, forming a solid intellectual property system that supports product quality, clinical application, and competitive market positioning.

• Driving Product Innovation Through Focused R&D

Hangzhou Zhengda Medical approaches product development with a focus on real-world clinical needs. Over the years, the company has optimized device structures and performance, gradually turning development challenges into patented solutions.

The company's patents cover key medical devices, including CPM machines, Electric Tourniquet Systems, Plaster Saws, and Compression Therapy Systems. These achievements focus on device structure, component integration, and adaptability, enabling repeated application across multiple product generations. This iterative approach ensures that innovations are not only practical but also form the foundation for long-term improvements in rehabilitation and surgical equipment.

By continuously refining designs, Hangzhou Zhengda Medical demonstrates the ability to transform R&D insights into stable technical solutions, strengthening both product performance and clinical reliability.

• Advancing Device Intelligence Through Software Development

Modern medical devices increasingly rely on software for improved control and patient safety. Hangzhou Zhengda Medical has expanded its R&D from hardware to software systems, standardizing device operation and management across product lines.

The company's software copyrights cover programs for Electric Tourniquet Systems, CPM machines, Plaster Saws, and Compression Therapy Systems, enabling precise control of treatment parameters, workflow management, and coordinated device operation.

Through continuous optimization, these software systems have achieved reuse across different products, reflecting Hangzhou Zhengda Medical’s long-term investment in intelligent and systematic device development.

• Supporting Future Growth With Strong Technical Foundations

The 46 patents and 13 software copyrights represent Hangzhou Zhengda Medical's commitment to innovation and technological leadership. Since its establishment, the company has focused on meeting clinical needs, overcoming technical challenges, and strengthening its intellectual property portfolio.

Looking forward, Hangzhou Zhengda Medical will continue to increase R&D investment, with a focus on CPM machines, Electric Tourniquet Systems, Plaster Saws, and Compression Therapy Systems. By advancing product performance and expanding technological capabilities, the company aims to provide reliable, high-quality solutions that improve clinical efficiency and patient care.

At the same time, Hangzhou Zhengda Medical is dedicated to protecting and applying intellectual property in practical clinical settings, ensuring that innovations deliver real value to healthcare providers and patients while establishing the company as a benchmark in the medical device industry.